Patient Centricity and Virtualizing Technologies in a COVID-19 World: White Paper
Hanover, MD -- (December 21, 2020) -- Today the Society for Clinical Research Sites (SCRS) in collaboration with Medidata, a Dassault Systèmes company, released a white paper “Patient Centricity and Virtualizing Technologies in a COVID-19 World.” The paper reports the results of a site survey conducted in the first half of 2020.
Sites reported an eagerness to use new technology that would increase patient centricity and flexibility, but they also reported significant barriers. Site responses provide a guide to the barriers that need to be removed to make technology beneficial to patients and workable for sites.
“We knew that sites saw the potential for these technologies and we had already heard some of the pain points,” said SCRS COO Allyson Small. “What this paper does is clarify the barriers that sites see both for themselves and their patients and provide a roadmap for technology companies, sponsors, and CROs to successfully integrate new technology solutions.”
“Some of these patient-centric tools and technologies have been available for a number of years but there’s been a bit of reluctance to adopt new solutions until now,” said Jackie Kent, EVP of Product at Medidata. “We need to eliminate patient barriers to participation and lower the patient burden by decreasing the number of traditional site visits. A key finding in this research shows sites are most interested in expanding their solutions to include virtual trials, eConsent and telemedicine in the next two years, helping improve patient recruitment, retention and the overall patient experience.”
A complimentary download of the white paper is available here.
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,600+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata, The Operating System for Life SciencesTM.
Society for Clinical Research Sites
Paul Oestreicher, External Communications Director